Frailty is a predictor for worse outcomes in patients hospitalized with Clostridioides difficile infection

被引:2
|
作者
Chaar, Abdelkader [1 ]
Yoo, Jin Woo [1 ]
Nawaz, Ahmad [1 ]
Rizwan, Rabia [1 ]
Agha, Osama Qasim [1 ]
Feuerstadt, Paul
机构
[1] Yale Sch Med, New Haven, CT USA
来源
ANNALS OF GASTROENTEROLOGY | 2024年 / 37卷 / 04期
关键词
Clostridioides difficile; colitis; frailty; Hospital Frailty Risk Score;
D O I
10.20524/aog.2024.0898
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Frailty has major health implications for affected patients and is widely used in the perioperative risk assessment. The Hospital Frailty Risk Score (HFRS) is a validated score that utilizes administrative billing data to identify patients at higher risk because of frailty. We investigated the utility of the HFRS in patients with Clostridioides difficile infection (CDI) to determine whether they were at risk for worse outcomes and higher healthcare resource utilization. Methods Using the 2017 National Inpatient Sample, we identified all adults with a primary diagnosis of CDI. We classified patients into 2 groups: those who had an HFRS <5 (NonFrailCDI) and those with a score >= 5 (FrailCDI). We assessed differences in hospital outcomes and healthcare resource utilization based on frailty status. Results We identified 93,810 hospitalizations, of which 54,300 (57.88%) were FrailCDI. FrailCDI patients were at higher risk for fulminant CDI (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.6-2.3), requiring colectomy (OR 4.1, 95%CI 1.5-11.2), and inpatient mortality (OR 4.5, 95%CI 2.8-7.1). Furthermore, FrailCDI patients had higher odds of requiring Intensive Care Unit admission (OR 13.7, 95%CI 6.3-29.9) or transfer to another facility on discharge (OR 2.2, 95%CI 2.0-2.4), and had longer hospital stays and higher total charges when compared with NonFrailCDI. Conclusions Frailty as defined by the HFRS is an independent factor for worse outcomes and higher healthcare utilization in adults admitted for CDI. Risk stratifying patients by frailty may improve outcomes.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 50 条
  • [31] Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients
    Banegas, Marcela
    Villafuerte-Galvez, Javier
    Paredes, Rodrigo
    Sprague, Rebecca
    Barrett, Caitlin
    Gonzales-Luna, Anne J.
    Daugherty, Kaitlyn
    Garey, Kevin W.
    Xu, Hua
    Lin, Qianyun
    Wang, Lamei
    Chen, Xinhua
    Pollock, Nira R.
    Kelly, Ciaran P.
    Alonso, Carolyn D.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (03):
  • [32] Frequency of Clostridioides difficile Infection Among Hospitalized Patients in Kerman City, Iran
    Shojaei, Mohammad Saeed
    Rokhbakhsh-Zamin, Farokh
    Zarandi, Ebrahim Rezazadeh
    Sarafzadeh, Farhad
    Khoshroo, Sayed Mohammad Reza
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2022, 15 (12)
  • [33] Clostridioides difficile infection in immunocompromised hospitalized patients is associated with a high recurrence rate
    Avni, Tomer
    Babitch, Tanya
    Ben-Zvi, Haim
    Hijazi, Rabab
    Ayada, Gida
    Atamna, Alaa
    Bishara, Jihad
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 90 : 237 - 242
  • [34] Clostridioides difficile Infection in Stem Cell Transplant Recipients in Hospitalized Patients in the US
    Kamal, Muhammad
    Shabbir, Arafat
    Hayat, Umar
    Waqar, Maham
    Abbas, Sakina
    Nadeem, Asim
    Khakwani, Anum
    Faheela, Fnu
    Khan, Zubair
    Haseeb, Muhammad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S204 - S204
  • [35] Clostridioides difficile Infection in COVID-19 Hospitalized Patients: A Nationwide Analysis
    Deda, Xheni
    Elfert, Khaled
    Gandhi, Mustafa
    Malik, Alexander
    Elromisy, Esraa
    Guevara, Nehemias
    Nayudu, Suresh
    Bechtold, Matthew
    GASTROENTEROLOGY RESEARCH, 2023, 16 (04) : 234 - 239
  • [36] Risk Factors for Inappropriate Clostridioides difficile Infection Testing Among Hospitalized Patients
    Axenfeld, Ellen
    Greendyke, William G.
    Li, Jianhua
    Green, Daniel
    Whittier, Susan S.
    Freedberg, Daniel E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S621 - S621
  • [37] The Impact of Clostridioides Difficile Infection in Hospitalized Patients: What Changed during the Pandemic?
    Boeriu, Alina
    Roman, Adina
    Dobru, Daniela
    Stoian, Mircea
    Voidazan, Septimiu
    Fofiu, Crina
    DIAGNOSTICS, 2022, 12 (12)
  • [38] Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile Infection
    Alonso, Carolyn D.
    Papamichael, Konstantinos
    Sprague, Rebecca
    Barrett, Caitlin
    Gonzales-Luna, Anne J.
    Daugherty, Kaitlyn
    Garey, Kevin W.
    Villafuerte-Galvez, Javier
    Xu, Hua
    Lin, Qianyun
    Wang, Lamei
    Chen, Xinhua
    Pollock, Nira R.
    Kelly, Ciaran P.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
  • [39] NONALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH BETTER OVERALL OUTCOMES BUT WORSE INTESTINAL COMPLICATIONS IN PATIENTS HOSPITALIZED WITH CLOSTRIDIOIDES DIFFICILE INFECTION: INSIGHT FROM NATIONAL INPATIENT DATABASE
    Jiang, Yi
    Meybodi, Mohamad Aghaie
    Damiris, Konstantinos
    Pyrsopoulos, Nikolaos T.
    HEPATOLOGY, 2020, 72 : 984 - 984
  • [40] Outcomes of Clostridioides difficile Infection in Patients With Liver Cirrhosis: A Nationwide Study
    Abdalla, Abubaker O.
    Pisipati, Sailaja
    Elnaggar, Mohamed
    Rishi, Mohit
    Doshi, Rajkumar
    Gullapalli, Nageshwara
    GASTROENTEROLOGY RESEARCH, 2020, 13 (02) : 53 - 57